trial · primary record
Guselkumab
Crohn's Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 120 |
| Primary completion | 2028-08-14 |
| Primary endpoint | Percentage of Participants with Clinical Remission at Week 52 |
| Registry ID | NCT05923073 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:45.796Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05923073
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Guselkumab · approval
- Guselkumab · compound